Join us at our booth to discover how you can capture critical biological mechanisms that conventional models often miss. With our multi-organ microphysiological systems (MPS), you can isolate tissue-specific ADME parameters to de-risk your pipeline with human-relevant translational data.

Our approach enables physiological profiling across critical pharmacokinetic areas. This includes evaluating human oral bioavailability through first-pass metabolic and individual gut and liver contributions, as well as generating precise metabolism, clearance, and metabolite production data. Furthermore, our platform allows you to quantify dynamic transport for absorption profiles and separate intricate drug-drug interaction (DDI) risks across organs.

So, let’s change the game, together with a platform like no other. Meet the new easy to adopt, adapt and scale MPS – PhysioMimix® Core. Interact with its Multi-chip consumables plates and explore our range of validated protocols.

Our dedicated team will be at hand to answer your questions and share over a decade of Organ‑on‑a‑Chip (OOC)/ MPS expertise. Discover how you can enhance data translatability, optimize in vivo study design, and support confident preclinical decision‑making using more predictive, human‑relevant approaches that are in line with regulatory roadmaps to reduce animal testing.